AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Turn Therapeutics Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG002QTLH84
10.28▲ 0.10 (0.98%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
—
EBITDA
—
Diluted EPS (TTM)
—
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
10.18
Day's Range
10.09 – 10.79
52-Week Range
2.57 – 16.45
Volume
87.0K
Avg Volume
133.8K
Share Statistics
Shares Outstanding
Employees
2
Exchange
XNAS
Listed
2025-10-08
Share count as of August 12, 2026

Turn Therapeutics Inc. Common Stock (TTRX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Turn Therapeutics Inc. Common Stock (TTRX)
What is Turn Therapeutics Inc. Common Stock's Market Cap?
Turn Therapeutics Inc. Common Stock's Market Cap is $306.2M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · TTRXAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024
Operating expenses:
General and administrative
Research and development
Total operating expenses
Loss from operations
Other income (expense):
Net loss from change in fair value of derivative liability instrument——
NET LOSS
Basic net loss per common share
Diluted net loss per common share